Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: a Feasibility Study

NCT07129655 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT07129655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: a Feasibility Study
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
September 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary atresia, kasai portoenterostomy status, cholangitis